We've built the first AI foundation model for phenotypic drug discovery that predicts how any cell responds to any drug. Imagine running millions of assays instantly with zero lab work. It cuts the time and cost needed for drug screening by 60x, helping pharma test millions of compounds virtually and skip years of trial-and-error. It can even predict how new compounds might work or fail before they're ever tested, uncovering promising treatments and detecting side effects early on.